Yi Sang 4

What Happened
Yi Sang, Group President, Asia Pacific at Zimmer Biomet (ZBH), converted a total of 9,414 restricted stock units (RSUs) on 2026-03-06 (7,050 + 2,364). The Form 4 reports these as derivative exercises/conversions with an acquisition price of $0.00 and matching dispositions of the same 9,414 shares also at $0.00, resulting in no reported cash paid or proceeds and no net increase in beneficial ownership shown in the transaction lines.

Key Details

• Transaction date: 2026-03-06; filing date: 2026-03-10. No late-file flag indicated in the provided data.
• Reported entries: Acquired 7,050 shares @ $0.00 and 2,364 shares @ $0.00; Disposed 7,050 and 2,364 shares (derivative) @ $0.00. Total converted: 9,414 RSUs.
• Price/Value: Reported exercise/conversion price $0.00; no cash value or proceeds shown on the reported lines.
• Shares owned after transaction: Not specified in the provided excerpt of the filing.
• Footnote: F1 — Each RSU represents a contingent right to receive one share of Company common stock.

Context

• These entries reflect conversion/settlement of RSUs (derivative instruments). The simultaneous acquisition and disposition lines are commonly used when shares are withheld or sold immediately to cover taxes or administered as a cashless settlement; the filing itself does not state the reason.
• Because there is no reported purchase (P) or net acquisition, this transaction is not a straightforward bullish signal—it's an equity compensation settlement rather than an open-market buy or discretionary sale.